Aliso Viejo-based RxSight has tapped Tarsus Pharmaceuticals’ former Chief Commercial Officer Aziz Mottiwala as its new CEO.

Aziz Mottiwala becomes RxSight CEO July 20 amid commercial challenges. The move follows the $200M Alcon deal for adjustable ...

RxSight, Inc. (NASDAQ: RXST) today announced a planned leadership transition effective July 20, 2026, with Aziz Mottiwala ...

ALC is developing adjustable presbyopia-correcting lenses that pair advanced optics with post-surgery light adjustment.

Imagine stepping onto the pickleball court and seeing every line sharp and bright—no glasses, just Florida sunshine. That ...

Key Points Interested in RxSight, Inc.? Here are five stocks we like better. RxSight's preliminary Q2 sales fell 20% year ...

Alcon and RxSight, Inc have announced a non-exclusive collaboration to jointly develop adjustable presbyopia-correcting intraocular lenses (PCIOLs), a pairing that would bring post-operative ...

Omaha, Nebraska - July 10, 2026 - PRESSADVANTAGE - ilumin Eye Care Center, an ophthalmology practice located in Omaha, ...

Despite near-term headwinds, RxSight has long-term upside from the Alcon royalty partnership, stronger margins and discounted ...

We recently compiled a list of the 10 Best Innovative Healthcare Stocks to Buy Now. Alcon Inc. (NYSE:ALC) is one of the best healthcare stocks on our list. TheFly reported on July 2 that Argus lowered ...

Please provide your email address to receive an email when new articles are posted on . The lens will combine light-adjustable technology from RxSight with optical designs from Alcon. RxSight will ...

RxSight, Inc. (NASDAQ: RXST) today announced select preliminary financial results for the second quarter of 2026 and updates to its standalone product pipeline, following the announcement of the ...